How much funding has Bota Bio raised?

Bota Bio has raised $115.0M in total funding, most recently a Series B round.

Who are Bota Bio's investors?

Bota Bio's investors include Source Code Capital, Sequoia Capital, Matrix Partners China.

Where is Bota Bio headquartered?

Bota Bio is headquartered in Hangzhou, China.

What industry is Bota Bio in?

Bota Bio operates in Biotech, Synthetic Biology.

Bota Bio

Let Biotechnology Illuminate Daily Lives

Hangzhou, China · Founded 2019 · $115.0M raised

Biotech

Synthetic Biology

Headquarters: Hangzhou
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: bota.bio
Total Funding: $115.0M
Last Round: $100.0M Series BJul 2021
Rounds: 2

About

Bota Bio (Bota Biosciences, 恩和科技) is an industrial synthetic biotechnology company founded in 2019 and headquartered in Hangzhou, China with a US office in Lafayette, California. The company operates a proprietary Biofoundry platform combining computer algorithms and state-of-the-art biotechnologies to develop sustainable bio-manufacturing solutions. Products include bio-preservatives, nutritional supplements, performance proteins, and personal care ingredients under brands HeliaGenesis and YuccaElements. Bota Bio raised $100 million in Series B financing in 2021, with total funding of $145 million. BASF Venture Capital is among its investors. The company has a 130,000 m² fermentation production plant with over 600 tons annual capacity.

Summary

Bota Bio is a Biotech company based in Hangzhou, China, founded in 2019. It has raised $115.0M in total across 2 rounds, most recently a $100.0M Series B round in Jul 2021. Investors include Source Code Capital, Sequoia Capital and Matrix Partners China.